The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon
Work +46 8 578 450 00
Fax +46 8 578 450 99

Show all Press releases

Hammarskiöld & Co represented Morgan Stanley in the Sale of Mölnlycke Health Care Group

September 2010

Hammarskiöld & Co, has together with Cleary Gottlieb Steen & Hamilton, represented Morgan Stanley Principal Investments, including an affiliated entity, in the sale to Investor of its 34 per cent equity stake in Mölnlycke Health Care Group for a cash consideration of EUR 510 million (approx. SEK 5 billion).

Mölnlycke is a world leading manufacturer and provider of surgical and wound care products. Subsequent to the transaction, which is subject to competition clearance, Investor will own 96% of Mölnlycke.

Hammarskiöld & Co's team consisted of, among others, Lars Ulrichs (partner), Jakob Falkman (partner), and Magnus Bohman (associate).


Hammarskiöld & Co is a business law firm. The firm’s lawyers have broad experience across the range of legal issues that companies can expect to confront. Although the core of the firm’s practice focuses on Swedish law, the firm also has substantial expertise in advising on or handling the international implications of business law issues.

Legal Developments by:

  • Related party rules

    New Swedish closely related party rules for listed companies: On 31 January 2012, the Swedish Securities Council issued a new set of closely related party rules which may have a substantial impact on the business and ownership of listed companies in Sweden. Partners Peder Grandinson and Ulf Grubbström of Hammarskiöld & Co comment on the new rules and possible consequences thereof.
    - Hammarskiöld & Co

Legal Developments in Sweden

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to